TheProfitWatch

AMLX - Amylyx Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
14.51 1.27 (8.75%) --- --- --- 0.07 (0.48%) 1.18 (8.08%) --- 0.07 (0.48%)

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.46
Diluted EPS:
-0.46
Basic P/E:
-34.3043
Diluted P/E:
-34.3043
RSI(14) 1m:
63.81
VWAP:
15.78
RVol:
1.601

Events

Period Kind Movement Occurred At
1m Price decrease 1m 15.56 -0.2 (-1.27%) Oct 15 15:40
60m Price increase 60m 14.8 +0.76 (+5.41%) Oct 15 10:37
1m Price decrease 1m 14.16 -0.21 (-1.5%) Oct 15 09:44

Related News